Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06100874
What this trial is testing

A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)

Who this might be right for
Her 2 Positive Breast CancerBreast Cancer FemaleBreast Cancer Metastatic
Adrienne G. Waks 28
Not applicableStudy completedNCT03669497
What this trial is testing

Hypo-Fractionated Radiotherapy in Breast Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer
Tata Medical Center 33
Not applicableNot Yet RecruitingNCT07517224
What this trial is testing

Assessing the Effect of an Aerobic Exercise Program on Vascular Function in Women With Non-Metastatic Breast Cancer

Who this might be right for
Breast Cancer Survivors
Loyola University 40
Early research (Phase 1)Looking for participantsNCT07046923
What this trial is testing

LY4175408 in Participants With Advanced Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaEndometrial Neoplasms+2 more
Eli Lilly and Company 240
Not applicableStudy completedNCT02662868
What this trial is testing

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Who this might be right for
Metastatic Breast Cancer
Latin American Cooperative Oncology Group 767
Not applicableStudy completedNCT05424068
What this trial is testing

Rehabilitation for People With Advanced Cancer

Who this might be right for
Advanced Breast CancerAdvanced Colorectal CancerCancer Rehabilitation
University Health Network, Toronto 111
Testing effectiveness (Phase 2)Ended earlyNCT03241810
What this trial is testing

Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Elevation Oncology 22
Testing effectiveness (Phase 2)WithdrawnNCT00217659
What this trial is testing

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Active Not RecruitingNCT05548127
What this trial is testing

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

Who this might be right for
Breast Cancer
Pfizer 37
Not applicableLooking for participantsNCT07085442
What this trial is testing

Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery

Who this might be right for
Breast CancerAxillary Lymph Nodes DissectionAxillary Metastases+4 more
University Hospitals of Derby and Burton NHS Foundation Trust 400
Large-scale testing (Phase 3)UnknownNCT01710605
What this trial is testing

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Who this might be right for
Ductal Infiltrating Metastatic Breast CancerHormone-receptors Positive Breast Cancer
Institut Curie 800
Testing effectiveness (Phase 2)Study completedNCT00915018
What this trial is testing

Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Puma Biotechnology, Inc. 479
Not applicableActive Not RecruitingNCT07238023
What this trial is testing

Promoting Active Living Among People With Advanced Cancer

Who this might be right for
Metastatic Invasive Breast CancerMetastatic Invasive Gynecologic Cancer
University of Oklahoma 36
Large-scale testing (Phase 3)Looking for participantsNCT07461454
What this trial is testing

YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced or Metastatic Breast Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. 376
Early research (Phase 1)Active Not RecruitingNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Testing effectiveness (Phase 2)Study completedNCT00875979
What this trial is testing

Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 67
Testing effectiveness (Phase 2)Study completedNCT00015886
What this trial is testing

Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences 25
Large-scale testing (Phase 3)Looking for participantsNCT06957886
What this trial is testing

BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer

Who this might be right for
HER2-low Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 566
Testing effectiveness (Phase 2)Study completedNCT00423917
What this trial is testing

Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 36
Testing effectiveness (Phase 2)Study completedNCT01964924
What this trial is testing

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeInvasive Breast Carcinoma+4 more
National Cancer Institute (NCI) 37
Next Page